Assetmark Inc. Has $110,000 Position in Option Care Health, Inc. $OPCH

Assetmark Inc. cut its position in shares of Option Care Health, Inc. (NASDAQ:OPCH) by 85.1% during the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 3,969 shares of the company’s stock after selling 22,721 shares during the quarter. Assetmark Inc.’s holdings in Option Care Health were worth $110,000 at the end of the most recent quarter.

Several other large investors have also recently added to or reduced their stakes in OPCH. Durable Capital Partners LP grew its holdings in shares of Option Care Health by 134.2% during the 2nd quarter. Durable Capital Partners LP now owns 8,237,577 shares of the company’s stock worth $267,557,000 after purchasing an additional 4,720,988 shares in the last quarter. Norges Bank bought a new position in Option Care Health in the second quarter worth $69,932,000. Swedbank AB acquired a new stake in Option Care Health during the third quarter worth $49,455,000. Arrowstreet Capital Limited Partnership increased its holdings in Option Care Health by 109.0% in the 2nd quarter. Arrowstreet Capital Limited Partnership now owns 3,410,394 shares of the company’s stock valued at $110,770,000 after buying an additional 1,778,279 shares during the period. Finally, Jennison Associates LLC increased its holdings in Option Care Health by 145.6% in the 2nd quarter. Jennison Associates LLC now owns 2,138,248 shares of the company’s stock valued at $69,450,000 after buying an additional 1,267,660 shares during the period. Institutional investors and hedge funds own 98.05% of the company’s stock.

Analyst Upgrades and Downgrades

A number of equities analysts have recently commented on the stock. Citizens Jmp reaffirmed a “market outperform” rating and set a $38.00 price objective (up from $36.00) on shares of Option Care Health in a report on Tuesday, January 13th. Barrington Research raised their price target on shares of Option Care Health from $38.00 to $42.00 and gave the stock an “outperform” rating in a research note on Friday, January 16th. Wall Street Zen upgraded Option Care Health from a “hold” rating to a “buy” rating in a research note on Saturday, January 10th. Citigroup reissued an “outperform” rating on shares of Option Care Health in a report on Tuesday, January 13th. Finally, National Bank Financial set a $37.00 price target on Option Care Health in a research note on Tuesday, January 27th. One investment analyst has rated the stock with a Strong Buy rating, nine have given a Buy rating and two have assigned a Hold rating to the stock. According to data from MarketBeat, Option Care Health presently has a consensus rating of “Moderate Buy” and an average target price of $37.58.

Option Care Health Trading Up 1.1%

Shares of OPCH opened at $36.09 on Tuesday. The company has a debt-to-equity ratio of 0.85, a quick ratio of 1.05 and a current ratio of 1.56. The company has a market cap of $5.73 billion, a price-to-earnings ratio of 28.64, a PEG ratio of 2.13 and a beta of 0.84. The stock has a fifty day moving average price of $33.97 and a two-hundred day moving average price of $30.47. Option Care Health, Inc. has a 52-week low of $24.24 and a 52-week high of $36.80.

Option Care Health Profile

Option Care Health (NASDAQ: OPCH) is a leading provider of home and alternate site infusion services in the United States. The company specializes in the administration of injectable therapies, including antibiotics, nutrition, hydration, immunoglobulin, pain management and specialty pharmaceuticals. Through its nationwide network of infusion pharmacies and nursing professionals, Option Care Health delivers customized care plans and in-home nursing visits to patients managing complex or chronic conditions outside of a hospital setting.

Option Care Health traces its current structure to the completion of its merger with BioScrip in early 2021, combining two of the industry’s most experienced home infusion businesses.